PGC-1α Promotes the Growth of ErbB2/Neu–Induced Mammary Tumors by Regulating Nutrient Supply

Findings suggest that breast cancer patients with HER2-positive tumors might benefit from the most by treatment with anti-angiogenic drugs, an important question of great current interest.